| Literature DB >> 35260618 |
Maciej Jan Rybicki1, Ilse Becue2, Els Daeseleire2, Anna Klimek-Turek3, Tadeusz Henryk Dzido3.
Abstract
Solvent Front Position Extraction is a novel technique developed for effective sample preparation of biological samples containing coccidiostats prior to LC-MS/MS. In this study the technique was used for isolation and determination of seven coccidiostats, from both main groups being: ionophores and chemical coccidiostats. Its effectiveness was evaluated by comparing with other sample preparation procedures, used in European routine laboratories. Results obtained by Solvent Front Position Extraction were very satisfactory (linearity R2 ≥ 0.971, recovery 90.1-111.1%, RSDr: 8.7-16.6%, RSDR: 9.0-17.7%) and fulfilled requirements described in Commission Regulation (EU) 2021/808 of 22 March 2021, which showed great potential of the technique in sample preparation of coccidiostats in poultry feed.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35260618 PMCID: PMC8904545 DOI: 10.1038/s41598-022-07587-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Concentrations of individual coccidiostats in the feed samples used to plot the calibration curve points listed in the table (mg/kg).
| Substance | 0.25 ML | 0.5 ML | 1 ML | 1.25 ML | 1.5 ML | 1.75 ML | 2 ML | 4 ML |
|---|---|---|---|---|---|---|---|---|
| Robenidine | 0.175 | 0.35 | 0.7 | 0.875 | 1.05 | 1.225 | 1.4 | 2.8 |
| Nicarbazin (DNC) | 0.125 | 0.25 | 0.5 | 0.625 | 0.75 | 0.875 | 1 | 2 |
| Lasalocid | 0.3125 | 0.625 | 1.25 | 1.5625 | 1.875 | 2.1875 | 2.5 | 5 |
| Salinomycin | 0.175 | 0.35 | 0.7 | 0.875 | 1.05 | 1.225 | 1.4 | 2.8 |
| Monensin | 0.3125 | 0.625 | 1.25 | 1.5625 | 1.875 | 2.1875 | 2.5 | 5 |
| Narasin | 0.175 | 0.35 | 0.7 | 0.875 | 1.05 | 1.225 | 1.4 | 2.8 |
| Maduramycin | 0.0125 | 0.025 | 0.05 | 0.0625 | 0.075 | 0.0875 | 0.1 | 0.2 |
Figure 1Steps of sample preparation by Solvent Front Position Extraction—explanation in the text. The dashed lines mark the path of the pipette delivering the eluent, the arrows indicate the directions of the eluent migration. 1—pipette delivering the eluent, 2—starting spots of the samples, 3—matrix components of higher retention than the substances of interest, 4—the zone of substances of interest (coccidiostats), 5—the low retention matrix components, 6—TLC-MS Interface head. Stationary phase: HPTLC Silica gel.
MRM transitions.
| Substance | Precursor ion (m/z) | Product ion (m/z) | Collision energy (eV) | Polarity | Cone voltage (V) |
|---|---|---|---|---|---|
| Maduramycin | 939.0 | 877.5 | 50 | Positive | 34 |
| Narasin | 787.4 | 531.0 | 50 | Positive | 60 |
| Salinomycin | 773.4 | 531.3 | 32 | Positive | 64 |
| Nigericin | 747.5 | 703.4 | 70 | Positive | 60 |
| Monensin | 693.3 | 675.4 | 45 | Positive | 60 |
| Lasalocid | 613.6 | 359.3 | 20 | Positive | 48 |
| Robenidine | 334.0 | 110.9 | 50 | Positive | 30 |
| Nicarbazin (DNC) | 301.1 | 107.0 | 38 | Negative | 18 |
Average determination coefficients (R2) of calibration curves of coccidiostats in feed samples.
| Substance | Procedure 1 | Procedure 2 | Procedure 3 | Procedure 4 |
|---|---|---|---|---|
| Robenidine | 0.971 | 0.979 | 0.590 | 0.994 |
| Nicarbazin (DNC) | 0.979 | 0.989 | 0.989 | 0.966 |
| Lasalocid | 0.975 | 0.998 | 0.992 | 0.994 |
| Salinomycin | 0.984 | 0.998 | 0.996 | 0.999 |
| Monensin | 0.989 | 0.997 | 0.994 | 0.997 |
| Narasin | 0.979 | 0.998 | 0.997 | 0.998 |
| Maduramycin | 0.982 | 0.997 | 0.995 | 0.989 |
Recovery of coccidiostats in samples for each procedure.
| Substance | Procedure 1 | Procedure 2 | Procedure 3 | Procedure 4 |
|---|---|---|---|---|
| Robenidine | 111.0 | 99.8 | 79.6 | 88.5 |
| Nicarbazin (DNC) | 90.4 | 123.0 | 129.6 | 94.5 |
| Lasalocid | 103.2 | 98.6 | 97.0 | 95.5 |
| Salinomycin | 90.1 | 101.9 | 102.3 | 99.5 |
| Monensin | 92.5 | 100.8 | 106.5 | 100.6 |
| Narasin | 99.7 | 101.3 | 98.6 | 100.1 |
| Maduramycin | 90.9 | 100.0 | 103.3 | 92.2 |
Within-laboratory repeatability and reproducibility of determination of coccidiostats for each procedure.
| Substance | Max level as calculated by Horwitz | Procedure 1 | Procedure 2 | Procedure 3 | Procedure 4 | |
|---|---|---|---|---|---|---|
| Robenidine | RSDr | 14.67 | 10.38 | 8.52 | 72.29 | 8.52 |
| RSDR | 22.00 | 10.44 | 11.86 | 67.67 | 12.36 | |
| Nicarbazin (DNC) | RSDr | 14.67 | 9.07 | 6.83 | 5.55 | 20.94 |
| RSDR | 22.00 | 9.31 | 8.93 | 13.22 | 22.20 | |
| Lasalocid | RSDr | 10.67 | 9.38 | 25.77 | 6.99 | 5.69 |
| RSDR | 16.00 | 10.20 | 23.65 | 15.79 | 12.15 | |
| Salinomycin | RSDr | 14.67 | 8.66 | 7.35 | 4.83 | 5.89 |
| RSDR | 22.00 | 9.00 | 6.85 | 5.79 | 7.80 | |
| Monensin | RSDr | 10.67 | 9.32 | 7.44 | 7.02 | 6.43 |
| RSDR | 16.00 | 10.80 | 7.90 | 8.79 | 6.52 | |
| Narasin | RSDr | 14.67 | 11.14 | 6.77 | 5.04 | 5.63 |
| RSDR | 22.00 | 10.54 | 6.75 | 5.38 | 7.85 | |
| Maduramycin | RSDr | 16.67 | 16.59 | 6.67 | 6.12 | 8.24 |
| RSDR | 25.00 | 17.70 | 6.94 | 7.90 | 14.76 | |
CCα of coccidiostats for each procedure.
| Substance | ML in feed (μg/kg) | Procedure 1 | Procedure 2 | Procedure 3 | Procedure 4 |
|---|---|---|---|---|---|
| Robenidine | 700 | 833 | 835 | 1318 | 825 |
| Nicarbazin (DNC) | 500 | 568 | 590 | 640 | 672 |
| Lasalocid | 1250 | 1465 | 1728 | 1564 | 1487 |
| Salinomycin | 700 | 793 | 780 | 768 | 789 |
| Monensin | 1250 | 1454 | 1413 | 1441 | 1384 |
| Narasin | 700 | 820 | 778 | 760 | 790 |
| Maduramycin | 50 | 63 | 55 | 56 | 61 |
Limits of detection (LOD) for each procedure.
| Substance | ML in feed (μg/kg) | Procedure 1 | Procedure 2 | Procedure 3 | Procedure 4 |
|---|---|---|---|---|---|
| Robenidine | 700 | 274 | 185 | 5911 | 110 |
| Nicarbazin (DNC) | 500 | 166 | 120 | 107 | 166 |
| Lasalocid | 1250 | 453 | 173 | 233 | 198 |
| Salinomycin | 700 | 204 | 67 | 92 | 58 |
| Monensin | 1250 | 301 | 136 | 213 | 118 |
| Narasin | 700 | 230 | 73 | 79 | 60 |
| Maduramycin | 50 | 15 | 6 | 8 | 10 |
Times of sample preparation of each procedure per single sample.
| Procedure 1 | Procedure 2 | Procedure 3 | Procedure 4 | |
|---|---|---|---|---|
| Time per sample | 3 min | 4 min 20 s | 3 min 40 s | 6 min |